Table 2.
Treatment response and survival data for study dogs.
| Signalment 1 | Tumor Type and Location | Treatment Response | Progression Free Survival (Days) | Pattern of Failure | Overall Survival Time (Days) | Cause of Death |
|---|---|---|---|---|---|---|
| 12y MC Australian Terrier |
Melanoma (mandible) |
Progressive disease | 75 | Local, Regional, Distant | 452 | Local, Regional, Distant |
| 13y FS Mixed Breed |
Carcinoma (salivary gland) |
Stable disease | 115 | Distant | 477 | Local, Regional, Distant |
| 10y MC Labrador Retriever |
Melanoma (maxilla) |
Complete response | 147 | Local | 147 | Local |
| 3y MC German Shepherd |
Soft tissue sarcoma (mandible) |
Partial response | 127 | Local | 262 | Local |
| 9y FS Maltese |
Melanoma (maxilla) |
Complete response | 260 | Local | 371 (alive at the time of analysis) |
Alive at the time of analysis |
| 15y MC Mixed Breed |
Carcinoma (maxilla) |
Complete response | 154 | Local | 162 | Local |
| 13y FS Miniature Dachshund |
Carcinoma (salivary gland) |
Progressive disease | 19 | Regional (out-of-field) | 52 | Regional (out-of-field) |
| 8y MC Mixed Breed | Soft tissue sarcoma (maxilla) |
Stable disease | 114 | Distant | 224 | Distant |
| 10y MC Labrador Retriever |
Melanoma (maxilla) |
Partial response | 260 | Local, regional (nodal), distant | 635 | Local, Regional, Distant |
| 10y MC Mixed Breed |
Melanoma (maxilla) |
Partial response | 82 | No evidence of progression at time of death | 82 | Other (Acute collapse) |
| 10y FS Labrador Retriever |
Carcinoma (mandible) |
Progressive disease | 79 | Regional (out-of-field) | 192 | Other (Acute kidney injury) |
| 9y FS Miniature Poodle |
Soft tissue sarcoma (axilla) |
Stable disease | 433 (no progression) |
No evidence of progression at time of analysis | 433 | Alive at the time of analysis |
1 MC, male castrated; FS, female spayed.